ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Research Associate II, Oligonucleotide Synthesis at CRISPR Therapeutics - ApplyBlast

Research Associate II, Oligonucleotide Synthesis

CRISPR Therapeutics

9 days ago

3.1 on Glassdoor

South Boston, Massachusetts, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A hands-on Research Associate II supports the synthesis, purification, and conjugation of oligonucleotides for gene editing and targeted delivery programs. The role involves running solid-phase synthesis on automated platforms, purifying and characterizing crude material, and preparing small molecule and antibody conjugates. This bench-intensive position requires executing defined experimental plans with high quality and throughput while delivering reliable material to study teams.

Responsibilities

Execute solid-phase oligonucleotide synthesis on automated platforms
Purify and characterize crude oligonucleotides using HPLC and LC-MS
Prepare small molecule and antibody conjugates for targeted delivery

Skills

Qualifications

BS in ChemistryBS in BiochemistryBS in Chemical BiologyMS in ChemistryMS in Biochemistry

About CRISPR Therapeutics

crisprtx.com

Headquarters

Boston, Massachusetts, United States

Company Size

201-500 employees

Founded

2013

View Profile

CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.